TriAgenics

Imagine Eliminating Wisdom Teeth Extractions with a Non-Surgical Procedure!

Print
Claim My Business
Min Investment
$300
Location
REDMOND, OR
Offering Date
June 07, 2023
Expected Close Date
July 15, 2024
Target Raise
$15.00K-$4.00M
No. Investors
815
Security Price
$3
Website
triagenics.com
Number of Employees
2
Cash
$669,892
Revenue
$0
Short Term Debt
$85,782
Cost of Goods
$0
Long Term Debt
$0
Net Income
$-1,442,937

Company Description

TriAgenics is demonstrating the efficacy of our Zero3 Tooth Bud Ablation (TBA) product. We are pre-revenue and have completed pre-production prototype development. We are now scaling manufacturing of our Zero3 TBA product in preparation for applying to the FDA for premarket clearance.

Management Team / Advisory Board Bios

Leigh ColbyPresident, CEO, Corporate Secretary, and Director From 1995 through 2015, Leigh was the founder, CEO, and sole shareholder of Oregon Dental Care, a successful group dental practice in Oregon that delivers high-quality patient care in a zero-defect operating environment. In late 2015, Oregon Dental Care was acquired by InterDent, where he served as the Managing Clinical Director. Prior to starting Oregon Dental Care in 1995, Leigh was involved with three high-tech startups that all remain in successful operation today. In 1980, he was the principal founder of Laserdyne Corporation and wrote the ground-breaking specifications for the successful high-resolution Beam Director general-purpose CNC laser machining system. The Beam Director system remains the #1 selling general-purpose laser machining system worldwide. In 1984, he assisted the PhD EE founder of Cyberoptics Corporation in defining their initial product specifications and market applications to establish initial distribution channels for their unique high- resolution, non-contact laser gauging and automated inspection products. Leigh worked with CyberOptics to develop and implement a marketing plan that drove initial product sales and propelled them to a market leader, where they remain today. In 1986, Leigh teamed up with three PhD-level biochemists as their Vice President of Marketing to define and establish their first commercial operations for Surmodics, Inc. His 10-year effort at Surmodics ultimately resulted in revenues approaching $100M annually for the use of PhotoLink high-reliability biocompatibility enhancement technology on a variety of widely recognized implant and disposable medical devices. Surmodics remains a publicly traded operation. Leigh has earned his M.B.A. degree from Northwest Christian University, D.D.S. and B.S. degrees from the University of Minnesota, and B.S. degree from St. John’s University and is a certified Lean Six Sigma Master Black Belt., David Paul WatsonDirector & Chief of OperationsDave brings 25 years of leadership experience to the management team at TriAgenics, Inc. Dave worked for 15 years with IBM in Engineering, Manufacturing, and Product Development, where he held key technical and senior management positions, including critical strategist at IBM Technology Products Division headquarters. He filled the positions of Director of Technology at Planar Systems, Inc., Director of Engineering at Fujitsu Ltd., Director of Manufacturing at Biotronik, Inc., and VP of Engineering at Unilife Medical Solutions, Inc. Dave has patents in the fields of automated equipment and technology products. Dave is the Chief of Operations at TriAgenics, Inc. and is responsible for quality assurance, regulatory affairs, product development, and manufacturing. He holds an MSME from the University of Texas and a BSME from California Polytechnic State University in California.
John Joseph Chopack JrBoard MemberJohn is VP Corporate Development for Neoss Ltd., a dental solutions company headquartered in Europe. He leads all external business development activities, including acquisitions and partnerships. 
Prior to joining Neoss, John was a Principal and founding partner of Inspiros Ventures. John managed the day-to-day operations of Inspiros and was responsible for investment origination, portfolio company management, and investor relations. Johnhas 20 years of experience in private equity/venture capital investing in medtech companies. As a General Partner at HealthpointCapital, a $800 million AUM medtech-focused private equity firm, John played an integral role in the firm’s most profitable investments – Nexa Orthopedics, BioHorizons, and Blue Belt Technologies. These investments brought significant advances to the healthcare field and provided top quartile returns to investors.
Prior to his career in venture capital, John was an orthopedic sales representative for Wright Medical and Encore Orthopedics. Following his experience as an orthopedic sales representative, John worked on Wall Street with Investec and Techvest as a medtech analyst.
John has been recognized as a “40 under 40 Medtech Innovator” by Medical Device and Diagnostic Industry Magazine.
John received a BA from Lafayette College and an MBA from Fordham University Gabelli School of Business.
Jeffrey Miles JacobsBoard MemberJeff is the former CEO of Stradis Healthcare, which was acquired in 2021 by Henry Schein, a Fortune 500 Company. He has more than 20 years of experience in the medical device packaging industry.
David Scott ThrowerBoard MemberDavid has more than 30 years of experience with medical device companies,ranging from VP of Marketing for Align Technology (makers of Invisalign) to CEO of several medical device start-ups. He has also served as a Board member of a number of companies, including Aerin Medical, uLab Systems, and Triagenics. David has experience in a wide range of company functions, including sales, marketing, R&D, business development, and manufacturing, for companies with both medical device and consumer applications.
George ShahinBoard MemberGeorge is board-certified in Internal Medicine and Gastroenterology by the American Board of Internal Medicine. He is a member of the American College of Gastroenterology and the American Medical Association.
Amount Raised : $3,310,538
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Research Reports

No reports have been submitted

Become a Reporter

0 Comments